
265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market
The Readout Loud
00:00
Introduction
The Readout Loud is a weekly biotech podcast from Stett. This week, we look at Novavax and Eli Lilly's weight loss in clinical trials. We also talk about the new CEO of Novavax who promises to change things for the better. And last but not least: What does operational inefficiency look like in clinical trials?
Transcript
Play full episode